Director, Global Medical Affairs - Rare Metabolic Disorders

Travere•San Diego, CA

2d•Remote

About The Position

Be a part of a global team that is inspired to make a difference in the lives of people living with rare disease. At Travere Therapeutics, we recognize that our exceptional employees are vital to our success. We are a dedicated team focused on meeting the unique needs of rare patients. Our work is rewarding – both professionally and personally – because we are making a difference. We are passionate about what we do. We are seeking talented individuals who will thrive in our collaborative, diverse, fast-paced environment and share in our mission – to identify, develop and deliver life-changing therapies to people living with rare disease. We stick by our values centered on patients, courage, community, and collaboration to pursue our vision of becoming a leading biopharmaceutical company dedicated to the delivery of innovation and hope to patients in the global rare disease community. At Travere Therapeutics, we are in rare for life. We continue to courageously forge new paths as we move toward a common goal of elevating science and service for rare patients. Position Summary: The Director, Global Medical Affairs – Rare Metabolic Disorders will serve as a strategic scientific leader supporting a Phase 3 asset in the genetic metabolic disease space. This individual will play a critical role in shaping and executing global medical strategy in preparation for potential regulatory approval and launch. The Director will act as a subject matter expert in inborn errors of metabolism, leading evidence generation planning, scientific narrative development, and external engagement with professional societies and key stakeholders. This role requires close collaboration with Clinical Development to translate Phase 3 data into a compelling and differentiated scientific story. The individual will work cross-functionally with Clinical Development, Commercial, Market Access, Medical Training, Scientific Communication and Field Medical teams to ensure alignment and readiness for launch, while establishing strong external partnerships that advance disease understanding and patient care.

Requirements

MD, MD/PhD, or equivalent (RD/PhD acceptable with strong clinical expertise). Equitable combination of skills and relevant experience are also considered
Minimum 6 years of relevant clinical or industry experience in Medical Affairs or related roles
Deep expertise in inborn errors of metabolism / genetic metabolic disorders
Experience supporting Phase 3 or pre-launch assets preferred
Proven experience in leading evidence generation and external engagement
Strong ability to translate complex clinical data into actionable insights
Experience engaging with professional societies and guideline bodies
Demonstrated strategic thinking and cross-functional leadership
Excellent communication and presentation skills
High ethical standards and compliance awareness

Responsibilities

Support overall Medical strategy for rare metabolic conditions
Translate Phase 1/2 and Phase 3 and other data into clear scientific insights and positioning
Provide strategic input across initiatives, ensuring scientific rigor and clinical relevance
Serve as the internal medical expert in rare metabolic disorders, with a strong foundation in inborn errors of metabolism
Lead integrated evidence generation planning aligned with Phase 3 and pre-launch needs
Identify and prioritize evidence gaps critical for regulatory, payer, and clinical adoption
Partner with Clinical Development to mine, interpret, and communicate Phase 3 data
Support planning of post-approval studies, registries, and real-world evidence generation
Develop and execute a strategic engagement plan with US professional societies and scientific organizations, and international organizations as needed
Build sustained collaborations beyond congress activities, including research and education initiatives
Engage with guideline bodies and scientific committees to align evidence generation with future guideline inclusion
Represent the company at advisory boards, congresses, and scientific forums
Map key external stakeholders and influence networks
Lead development of scientific messaging and communication strategy for the asset
Ensure consistency across publications, congress materials, and medical content
Support publication planning and execution aligned with Phase 3 milestones
Partner with Commercial and Market Access to ensure medical insights inform launch strategy
Collaborate with Clinical Development to align on data generation and interpretation
Work with Patient Advocacy and Government Affairs to align external initiatives
Support training for internal teams, including field medical and commercial teams
Provide strategic and scientific guidance to field medical teams
Support external engagement strategy execution through field teams